Literature DB >> 32026542

Natural products for the prevention and treatment of cholestasis: A review.

Xiao Ma1, Yinxiao Jiang1, Wenwen Zhang1, Jiabo Wang2, Ruilin Wang2, Lifu Wang2, Shizhang Wei1,3, Jianxia Wen1,3, Haotian Li3, Yanling Zhao3.   

Abstract

Cholestasis is a common manifestation of decreased bile flow in various liver diseases. It results in fibrosis and even cirrhosis without proper treatment. It is believed that a wide range of factors, including transporter dysfunction, oxidative stress, inflammatory damage, and immune disruption, can cause cholestasis. In recent years, natural products have drawn much attention for specific multiple-target activities in diseases. Many attempts have been made to investigate the anticholestatic effects of natural products with advanced technology. This review summarizes recent studies on the biological activities and mechanisms of recognized compounds for cholestasis treatment. Natural products, including various flavonoids, phenols, acids, quinones, saponins, alkaloids, glycosides, and so on, function as comprehensive regulators via ameliorating oxidative stress, inflammation, and apoptosis, restoring bile acid balance with hepatic transporters, and adjusting immune disruption. Moreover, in this progress, nuclear factor erythroid 2-related factor 2, reactive oxygen species production, heme oxygenase-1, NF-κB, cholesterol 7 alpha-hydroxylase, and farnesoid X receptors are thought as main targets for the activity of natural products. Therefore, this review presents the detailed mechanisms that include multiple targets and diverse signalling pathways. Natural products are the valuable when seeking novel therapeutic agents to treat cholestatic liver diseases.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bile acids homeostasis; cholestasis; liver injury; multiple targets; natural products

Mesh:

Substances:

Year:  2020        PMID: 32026542     DOI: 10.1002/ptr.6621

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease.

Authors:  Qichao Hu; Shizhang Wei; Jianxia Wen; Wenwen Zhang; Yinxiao Jiang; Caiyan Qu; Junbao Xiang; Yanling Zhao; Xi Peng; Xiao Ma
Journal:  BioData Min       Date:  2020-08-27       Impact factor: 2.522

Review 2.  Multi-Interactions in Ionic Liquids for Natural Product Extraction.

Authors:  Ying Zhang; Yingying Cao; Hui Wang
Journal:  Molecules       Date:  2020-12-28       Impact factor: 4.411

3.  Liposome Extract of Stachys pilifera Benth Effectively Improved Liver Damage due to Bile Duct Ligation Rats.

Authors:  Zahra Moslemi; Hassan Bardania; Izadpanah Gheitasi; Zahra Barmoudeh; Navid Omidifar; Hamidreza Parvin; Bahman Khalvati; Mohamad Hassan Fouani; Mohsen Alipour; Amir Hossein Doustimotlagh
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

4.  Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis.

Authors:  Ya Yang; Yanfei Chen; Yalei Zhao; Feiyang Ji; Lingjian Zhang; Shima Tang; Sainan Zhang; Qingqing Hu; Zuhong Li; Fen Zhang; Qian Li; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2022-02-05       Impact factor: 6.832

5.  Efficacy and Safety of Zuojin Pill for the Treatment of Chronic Nonatrophic Gastritis: A Randomized Active-Controlled Clinical Trial.

Authors:  Ruilin Wang; Yanling Wang; Zheng Lu; Jing Jing; Zhongxia Wang; Tingting He; Miao Tian; Zongyang Yuan; Yanfei Cui; Wenya Rong; Xiao Ma; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-07       Impact factor: 2.650

6.  Acacia sieberiana (Fabaceae) attenuates paracetamol and Bile Duct Ligation-Induced hepatotoxicity via modulation of biochemical and oxidative stress biomarkers.

Authors:  Miriam Watafua; Jane I Ejiofor; Aminu Musa; Mubarak Hussaini Ahmad
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

7.  Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis.

Authors:  Jiaxiong Ming; Qianqian Xu; Limin Gao; Yanfang Deng; Jie Yin; Qun Zhou; Qingyi Tong; Yonghui Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-11

Review 8.  Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review.

Authors:  Xiao Ma; Wenwen Zhang; Yinxiao Jiang; Jianxia Wen; Shizhang Wei; Yanling Zhao
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.